Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Japanese Journal of Cancer Research : Gann
|
April 13, 2000
Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells
M Enjoji, M Nakashima, M Nakamuta, et al.
Hepato-Gastroenterology
|
June 1, 1994
Benign recurrent intrahepatic cholestasis: a long-term follow-up
M Nakamuta, S Sakamoto, Y Miyata, et al.
The International Journal of Biological Markers
|
February 17, 2017
Urinary N1,N12-diacetylspermine levels correlate with HCV amount in patients with chronic hepatitis C
M Enjoji, E Arimura, M Kohjima, et al.
The Journal of Biological Chemistry
|
January 17, 1997
Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing
P P Lau, H J Zhu, M Nakamuta, et al.
The Journal of Laboratory and Clinical Medicine
|
July 13, 1999
Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion
H Iwamoto, H Sakai, S Tada, et al.
Digestive Diseases and Sciences
|
May 11, 1999
Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells
H Iwamoto, H Sakai, K Kotoh, et al.
Hepatology (Baltimore, Md.)
|
December 1, 1993
High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism
M Nakamuta, M Ohashi, Y Tanabe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 23, 1998
Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression
M Nakamuta, S Taniguchi, B Y Ishida, et al.
Human Gene Therapy
|
November 30, 2000
Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model
M Enjoji, F Wang, M Nakamuta, et al.
The Journal of Laboratory and Clinical Medicine
|
May 16, 2000
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth
H Iwamoto, M Nakamuta, S Tada, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Japanese Journal of Cancer Research : Gann
|
April 13, 2000
Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells
M Enjoji, M Nakashima, M Nakamuta, et al.
Hepato-Gastroenterology
|
June 1, 1994
Benign recurrent intrahepatic cholestasis: a long-term follow-up
M Nakamuta, S Sakamoto, Y Miyata, et al.
The International Journal of Biological Markers
|
February 17, 2017
Urinary N1,N12-diacetylspermine levels correlate with HCV amount in patients with chronic hepatitis C
M Enjoji, E Arimura, M Kohjima, et al.
The Journal of Biological Chemistry
|
January 17, 1997
Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing
P P Lau, H J Zhu, M Nakamuta, et al.
The Journal of Laboratory and Clinical Medicine
|
July 13, 1999
Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion
H Iwamoto, H Sakai, S Tada, et al.
Digestive Diseases and Sciences
|
May 11, 1999
Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells
H Iwamoto, H Sakai, K Kotoh, et al.
Hepatology (Baltimore, Md.)
|
December 1, 1993
High plasma concentration of myeloperoxidase in cirrhosis: a possible marker of hypersplenism
M Nakamuta, M Ohashi, Y Tanabe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 23, 1998
Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression
M Nakamuta, S Taniguchi, B Y Ishida, et al.
Human Gene Therapy
|
November 30, 2000
Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model
M Enjoji, F Wang, M Nakamuta, et al.
The Journal of Laboratory and Clinical Medicine
|
May 16, 2000
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth
H Iwamoto, M Nakamuta, S Tada, et al.
Page
of 7